Title:
A Phase I Study to Evaluate Safety and Early Signs of Efficacy of the Human Monoclonal Antibody-cytokine Fusion Protein IL12-L19L19.
Phase:
I
Contact:
Angela Diana Klein / Kontaktperson
Clinical Investigator:
Prof. Dr. med. Jessica Hassel
Registration:
Die Studie ist bei den U.S. National Institutes of Health(ClinicalTrials.gov) registriert. Siehe
NCT04471987
EU CTIS/EudraCT:
Keine Registernummer angegeben. N/A:
